Discrimination of Vanadium from Zinc Using Gene Profiling in Human Bronchial Epithelial Cells by Li, Zhuowei et al.
The advancement of microarray technology
has allowed investigators to examine simulta-
neously changes in thousands of genes
induced by environmental toxins. McDowell
et al. (2000), using gene array with more than
8,000 cDNAs, found patterns of gene expres-
sion consistent with acute lung injury in
nickel-treated mice. Sato et al. (1999) showed
changes in genes related to cell growth and
possibly carcinogenesis in rat lungs treated
with diesel particles. More recently, Andrew
et al. (2003) demonstrated distinct expression
patterns in human lung cells exposed to low
and high doses of arsenic. The capability of
microarrays to provide a snapshot view of
expression of a large number of genes may
help us generate mechanistic hypotheses as
well as identify biomarkers of exposure spe-
ciﬁc to environmental toxins. The availability
of such speciﬁc genomic biomarkers may be
important in determining the nature of envi-
ronmental exposures.
Vanadium is present in several environ-
mental settings, for example, during over-
hauling of oil-fired boilers and burning of
heavy fuel in power plants. Exposures to high
levels of V-rich particles produce upper and
lower respiratory symptoms (Levy et al. 1984;
Woodin et al. 1999, 2000). Intratracheal
administration of vanadyl sulfate (VOSO4)
and a V-rich pollutant dust, residual oil fly
ash (ROFA), increased pulmonary artery
pressure acutely in buffer-perfused rabbit
lungs (Huang et al. 2002) and constricted
isolated rat aortic rings (Cadene et al. 1997).
Particulate air V concentration correlated
with increases in heart rate variability index in
boilermakers (Magari et al. 2002). V or
ROFA altered the expression of many genes
and their protein products related to acute
stress (Carter et al. 1997; Gavett et al. 1997,
1999; Nadadur et al. 2000; Samet et al.
1998) and cell survival and tissue growth in
cultured cells (Chen et al. 2001; Huang et al.
2000; Zhang et al. 2001).
Zinc is ubiquitous in the natural environ-
ment, including ambient air (Walsh et al.
1994). Exposure to excessive Zn (via metal
fumes) is a potential hazard for industrial
workers who perform welding and smelting
operations. Inhalation of high concentrations
of zinc oxide or zinc chloride produce respira-
tory epithelial cell damage, inflammation,
and acute injury (Doig and Challen 1964;
Evans 1945; Kuschner et al. 1995; Matarese
and Matthews 1986; Nemery 1990; Pare and
Sandler 1954). Treatment of lung epithelial
cells in vitro with Zn compounds enhanced
inflammatory signaling and produced cyto-
toxicity and cell death (Riley et al. 2003;
Samet et al. 1998, 1999).
Although V and Zn belong to different
elemental classes in the periodic table, they
share many biologic properties. For example,
both metals are potent enhancers for phos-
phorylation of signaling proteins, including
mitogen-activated protein kinase (Samet et al.
1998) and epidermal growth factor receptors
(Wu et al. 1999), and both increase Ras activ-
ity (Wu et al. 2002) and interleukin-8 (IL8)
release (Samet et al. 1998). Many of these
effects may be attributed to the capability of
these metals to inhibit protein tyrosine phos-
phatase activity (Samet et al. 1999). Both V
and Zn also inhibit metabolic activity of the
cells (Riley et al. 2003). V and Zn may coexist
in the ambient environment after being
released from different emission sources
(Nriagu and Pacyna 1988). The development
of a biomarker that discriminates these metals
thus may help deﬁne the sources and nature of
exposures. In this study we hypothesized that
gene proﬁling may be used to discriminate V
from Zn in human bronchial epithelial cells
(HBECs). We sought to identify a small
group of genes that may serve as biomarkers of
exposure.
Materials and Methods
Cell culture. Two bronchoscopists obtained
bronchial epithelial cells from normal vol-
unteers through bronchoscopic bronchial
brushings following the same operational
guidelines (Ghio et al. 2000; Huang et al.
2003). Subjects were informed of the proce-
dures and potential risks, and each gave writ-
ten informed consent. The protocol was
approved by the University of North
Carolina School of Medicine Committee on
Protection of the Rights of Human Subjects
and by the U.S. Environmental Protection
Agency. A single experienced technician
processed all brushings by following the
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We hypothesized that gene expression proﬁling may discriminate vanadium from zinc in human
bronchial epithelial cells (HBECs). RNA from HBECs exposed to vehicle, V (50 µM), or Zn
(50 µM) for 4 hr (n = 4 paired experiments) was hybridized to Affymetrix Hu133A chips. Using
one-class t-test with p < 0.01, we identiﬁed 140 and 76 genes with treatment:control ratios ≥ 2.0
or ≤ 0.5 for V and Zn, respectively. We then categorized these genes into functional pathways and
compared the number of genes in each pathway between V and Zn using Fisher’s exact test. Three
pathways regulating gene transcription, inflammatory response, and cell proliferation distin-
guished V from Zn. When genes in these three pathways were matched with the 163 genes ﬂagged
by the same statistical ﬁltration for V:Zn ratios, 12 genes were identiﬁed. The hierarchical cluster-
ing analysis showed that these 12 genes discriminated V from Zn and consisted of two clusters.
Cluster 1 genes (ZBTB1, PML, ZNF44, SIX1, BCL6, ZNF450) were down-regulated by V and
involved in gene transcription, whereas cluster 2 genes (IL8, IL1A, PTGS2, DTR, TNFAIP3,
CXCL3) were up-regulated and linked to inflammatory response and cell proliferation. Also,
metallothionein 1 genes (MT1F, MT1G, MT1K) were up-regulated by Zn only. Thus, using
microarray analysis, we identiﬁed a small set of genes that may be used as biomarkers for discrimi-
nating V from Zn. The novel genes and pathways identiﬁed by the microarray may help us under-
stand the pathogenesis of health effects caused by environmental V and Zn exposure. Key words:
cell proliferation, inflammation, interleukin-1, interleukin-8, metal, microarray, transcription.
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http://dx.doi.org/ [Online 21 June 2005]established standard of procedures in our lab-
oratory. The cells (passage 2 or 3) were main-
tained in bronchial epithelial growth medium
(BEGM) (Clonetics, San Diego, CA), supple-
mented with bovine pituitary extract, insulin
5 µg/mL, hydrocortisone 0.5 µg/mL, genta-
micin 50 µg/mL, retinoic acid 0.1 ng/mL,
transferrin 10 µg/mL, triiodothyrodine
6.5 ng/mL, epinephrine 0.5 µg/mL, and
human epidermal growth factor 0.5 ng/mL.
Cells were judged to be 95–100% conﬂuent
at the time of metal treatment.
Metal treatment. Stock solutions of met-
als were prepared in sterile water (Baxter
Healthcare Corp., Deerfield, IL) and were
diluted with BEGM before experiments. Cells
were grown in 100-mm diameter petri dishes
and exposed to 5.5 mL of BEGM with or
without 50 µM VOSO4 or zinc sulfate
(ZnSO4) (Johnson Matthey Corp., Ward
Hill, MA) for 4 hr.
Purification and hybridization of RNA.
Total cellular RNA was extracted from
HBECs with Trizol reagent (GIBCO BRL
Life Technologies, Gaithersburg, MD) and
further puriﬁed with phenol/chloroform. The
RNA integrity was assessed with an Agilent
2100 bioanalyzer (Agilent Technologies, Inc.,
Palo Alto, CA). The 260:280-nm ratios for all
RNAs were > 1.9. The RNA hybridization to
the U133A GeneChip oligonucleotide
microarray (Affymetrix, Inc., Santa Clara CA)
was performed by Expression Analysis Inc.
(Durham, NC). Affymetrix Hu133A 2.0 gene
chips were used for the study. The chip con-
tained probes for 14,500 human genes.
Target was prepared and hybridized accord-
ing to the Affymetrix technical manual
(Affymetrix, Inc. 2004a). Total RNA (10 µg)
was converted into cDNA using reverse tran-
scriptase (Invitrogen Corp., Carlsbad, CA)
and a modiﬁed oligo(dT)24 primer that con-
tains T7 promoter sequences (GenSet Corp.,
San Diego, CA). After first-strand synthesis,
residual RNA was degraded by the addition
of RNaseH and a double-stranded cDNA
molecule was generated using DNA poly-
merase I and DNA ligase. The cDNA was
then purified and concentrated using a phe-
nol:chloroform extraction followed by
ethanol precipitation. The cDNA products
were incubated with T7 RNA polymerase,
and biotinylated ribonucleotides using an
in vitro transcription kit (Enzo Diagnostics
Inc., New York, NY). Half the cRNA prod-
ucts were purified using an RNeasy column
(Qiagen Inc., Valencia, CA) and quantified
with a spectrophotometer. The cRNA target
(20 µg) was incubated at 94°C for 35 min in
fragmentation buffer (Tris, magnesium
acetate, potassium acetate). The fragmented
cRNA was diluted in hybridization buffer
(2-morpholinoethanesulfonic acid, NaCl,
EDTA, Tween 20, herring sperm DNA,
acetylated bovine serum albumin) containing
biotin-labeled oligoB2 and eukaryotic
hybridization controls (Affymetrix). The
hybridization cocktail was denatured at 99°C
for 5 min, incubated at 45°C for 5 min, and
then injected into a GeneChip cartridge. The
GeneChip array was incubated at 42°C for at
least 16 hr in a rotating oven at 60 rpm.
GeneChips were washed with a series of non-
stringent (25°C) and stringent (50°C) solu-
tions containing variable amounts of
2-morpholinoethanesulfonic acid, Tween 20,
and SSPE (3 M NaCl, 0.2 M, NaH2PO4,
0.02 M EDTA). The microarrays were then
stained with streptavidin phycoerythrin, and
the fluorescent signal was amplified using a
biotinylated antibody solution. Fluorescent
images were detected in a GeneChip Scanner
3000 (Affymetrix), and expression data were
extracted using the default settings in the
MicroArray Suite 5.0 software (Affymetrix).
All GeneChips were scaled to a median inten-
sity setting of 500. Four independent sets of
experiments were performed on HBECs
obtained from four different individuals. Each
set consisted of control (vehicle), VOSO4,
and ZnSO4.
Quantitative polymerase chain reaction.
Quantitative polymerase chain reaction
(Q-PCR) was performed for selected genes to
validate microarray results. HBECs were lysed
in guanidine isothiocyanate (GITC) buffer
[4 M GITC (Boehringer Mannheim,
Indianapolis, IN), 25 mM sodium citrate
(pH 7.0), 0.5% sarkosyl, and 0.1 M DTT],
and RNA was pelleted at 80,000 rpm
through a cesium chloride gradient for 2 hr at
15°C. cDNAs were synthesized from 0.4 µg
of total RNA in 100 µL of a buffer containing
5 µM random hexaoligonucleotide primers
(Pharmacia, Piscataway, NJ), 10 U/µL
Moloney murine leukemia virus reverse
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Table 1. Genes up-regulated by VOSO4.
Gene
accession no.a Fold changeb Gene symbola Gene namea
Hs.624 8.04 IL8 interleukin 8
Hs.290873 6.67 PPEF2 protein phosphatase, EF hand calcium-binding domain 2
Hs.518417 5.52 STX6 syntaxin 6
Hs.233389 5.36 CPVL carboxypeptidase, vitellogenic-like
Hs.196384 4.67 PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H 
synthase and cyclooxygenase)
Hs.248189 4.46 KRTHA6 keratin, hair, acidic, 6
Hs.211600 4.33 TNFAIP3 tumor necrosis factor, alpha-induced protein 3
Hs.477070 4.30 CSNK1D casein kinase 1, delta
Hs.431460 4.24 ICAM2 intercellular adhesion molecule 2
Hs.44385 4.24 SBLF stoned B-like factor
Hs.799 4.21 DTR diphtheria toxin receptor (heparin-binding epidermal growth 
factor-like growth factor)
Hs.418167 4.16 ALB albumin
Hs.246310 4.11 JAM2 junctional adhesion molecule 2
Hs.406990 4.06 PDE4DIP phosphodiesterase 4D interacting protein (myomegalin)
Hs.992 4.04 PLA2G1B phospholipase A2, group IB (pancreas)
Hs.496222 3.97 ANGPTL1 angiopoietin-like 1
Hs.65758 3.78 ITPR3 inositol 1,4,5-triphosphate receptor, type 3
Hs.66713 3.70 DIPA hepatitis delta antigen-interacting protein A
Hs.519884 3.65 GCNT2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme
Hs.157259 3.64 SIPA1L3 signal-induced proliferation-associated 1-like 3
Hs.436023 3.56 PRDM1 PR domain containing 1, with ZNF domain
Hs.303980 3.51 CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide 1
Hs.236646 3.49 HOXD9 homeo box D9
Hs.171695 3.46 DUSP1 dual speciﬁcity phosphatase 1
Hs.197693 3.44 CACNG2 calcium channel, voltage-dependent, gamma subunit 2
Hs.485910 3.34 RARSL arginyl-tRNA synthetase-like
Hs.211238 3.30 IL1F9 interleukin 1 family, member 9
Hs.520319 3.30 SLC22A16 solute carrier family 22 (organic cation transporter), 
member 16
Hs.445555 3.22 SERPINI2 serine (or cysteine) proteinase inhibitor, clade I 
(neuroserpin), member 2
Hs.256667 3.20 PDK2 pyruvate dehydrogenase kinase, isoenzyme 2
Hs.248122 3.10 GPR24 G-protein-coupled receptor 24
Hs.511899 3.02 EDN1 endothelin 1
Hs.523506 2.99 WARS2 tryptophanyl tRNA synthetase 2 (mitochondrial)
Hs.333175 2.86 PLA2G12B phospholipase A2, group XIIB
Hs.410817 2.78 RPL13 ribosomal protein L13
Hs.520942 2.77 CLDN4 claudin 4
Hs.50823 2.74 PDCD6 programmed cell death 6
Hs.550498 2.72 RCE1 RCE1 homolog, prenyl protein protease (S. cerevisiae)
Hs.436023 2.67 PRDM1 PR domain containing 1, with ZNF domain
Hs.421724 2.66 CTSG cathepsin G
Continued, next pagetranscriptase (GIBCO BRL Life Technologies),
1 U/µL RNase inhibitor (RNasin; Promega,
Madison, WI), 0.5 mM dNTP (Pharmacia),
50 mM KCl, 3 mM MgCl2, and 10 mM
Tris-HCl (pH 9.3). After 1 hr of incubation at
39°C, the reverse transcriptase was heat inacti-
vated at 94°C for 4 min.
Q-PCR of specimen cDNA and standard
cDNA was performed using TaqMan master
mix (Perkin Elmer, Foster City, CA), 1.25 µM
probe, 3 µM forward primer, and 3 µM reverse
primer in a 50-µL volume. The probe, which
contains both a ﬂuorescence reporter dye at the
5´-end (6-carboxyfluorescein, 6-FAM: maxi-
mum emission wavelength = 518 nm) and a
quencher dye at the 3´-end (6-carboxytetra-
methyl rhodamine, TAMRA: maximum emis-
sion wavelength = 582 nm), is degraded by the
5´–3´ exonuclease activity of the Taq DNA
polymerase, and the resulting fluorescence is
detected by a laser in the sequence detector
(TaqMan ABI Prism 7700 Sequence Detector
System; PerkinElmer). The relative abundance
of mRNA levels was determined from standard
curves generated from a serially diluted stan-
dard pool of cDNA prepared from BEAS-2B
cells. The relative abundance of glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH)
mRNA was used to normalize levels of the
mRNAs of interest. Six additional sets of
Q-PCR experiments consisting of control
(vehicle), VOSO4, and ZnSO4 were performed
using HBECs from six different individuals.
Microarray data analysis. The microarray
data were deposited in the National Center for
Biotechnology Information (NCBI) Gene
Expression Omnibus database (http://www.
ncbi.nlm.nih.gov/geo/; accession number
GSE2111). Gene expression values were back-
ground corrected and normalized globally using
the default setting of the Affymetrix Microarray
Suite 5.0 software, and log2-transformed
according to the Affymetrix Statistical
Algorithm Reference Guide (Affymetrix, Inc.
2004b). The log2 ratios of treatment (V or
Zn) over control and V over Zn for all probe
sets were analyzed using the one-class t-test
against the null hypothesis of 0 (ratio = 1)
using the Multiexperiment Viewer (version
3.0; The Institute of Genomic Research,
Rockville, MD). A p-value of < 0.01 was con-
sidered statistically significant. If more than
one probe set for the same gene were ﬂagged,
their ratios were averaged.
Functional classiﬁcation of genes. Biologic
processes represented by the differentially
expressed genes were compiled using the
GOCharts in the Database for Annotation,
Visualization and Integrated Discovery
(DAVID) (http://apps1.niaid.nih.gov/david/)
with the coverage and speciﬁcity set at level 5
(high) and the hits threshold at 1; with 
the classification of the Gene Ontology
Consortium (http://www.geneontology.org);
and with the human gene resources from
NCBI (http://www.ncbi.nlm.nih.gov).
Comparison of the probe sets in the biologic
processes between V and Zn was determined
by the Fisher’s exact test (p < 0.05) (StatView
4.0; SAS Inc., Cary, NC).
Results
Differentially expressed genes associated with V
treatment. Incubation of HBECs with VOSO4
at 50 µM for 4 hr showed no cytotoxicity as
supported by the lack of lactate dehydrogenase
(LDH) release (data not shown). There were
140 differentially expressed genes with known
protein products. Seventy-six genes were
up-regulated with a treatment:control
ratio ≥ 2.0 (Table 1), and 64 genes were down-
regulated with a treatment:control ratio ≤ 0.5
(Table 2). The expression of ﬁve up-regulated
genes (IL8), prostaglandin-endoperoxide syn-
thase 2 (PTGS2), intercellular adhesion mole-
cule 2 (ICAM2), diphtheria toxin receptor
(heparin-binding epidermal growth factor-like
growth factor) (DTR), and dual specificity
phosphatase 1 (DUSP1) was confirmed by
Q-PCR in additional experiments (Figure 1).
The 140 genes could be further classiﬁed func-
tionally into 28 biologic processes containing
at least three gene hits.
Differentially expressed genes associated
with Zn treatment. Incubation of HBECs
with ZnSO4 at 50 µM for 4 hr also showed no
LDH release (data not shown). There were
76 differentially expressed genes with known
protein products. Forty-three genes were
up-regulated with a treatment:control ratio
≥ 2.0 (Table 3), and 33 genes were down-
regulated with a treatment:control ratio ≤ 0.5
(Table 4). The up-regulation of metalloth-
ionein 1F (MT1F) and heme oxygenase 1
(HMOX1) was confirmed by Q-PCR
(Figure 1). The 76 genes could be further
Gene profiling for vanadium and zinc
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Table 1. Continued.
Gene
accession no.a Fold changeb Gene symbola Gene namea
Hs.2250 2.63 LIF leukemia inhibitory factor (cholinergic differentiation factor)
Hs.282387 2.58 RPC32 polymerase (RNA) III (DNA directed) (32 kDa)
Hs.525389 2.56 ARHJ ras homolog gene family, member J
Hs.106019 2.54 PPP1R10 protein phosphatase 1, regulatory subunit 10
Hs.250281 2.52 SLC13A3 solute carrier family 13 (sodium-dependent dicarboxylate 
transporter), member 3
Hs.2128 2.48 DUSP5 dual-speciﬁcity phosphatase 5
Hs.89690 2.45 CXCL3 chemokine (C-X-C motif) ligand 3
Hs.11169 2.45 MIG-6 mitogen-inducible gene 6
Hs.789 2.41 CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth-
stimulating activity, alpha)
Hs.485004 2.37 ZNF306 zinc ﬁnger protein 306
Hs.534478 2.36 DUSP21 dual-speciﬁcity phosphatase 21
Hs.441972 2.34 IFNT1 interferon tau-1
Hs.503598 2.33 JMJD2D jumonji domain containing 2D
Hs.546252 2.25 EDG3 endothelial differentiation, sphingolipid G-protein-coupled 
receptor, 3
Hs.85862 2.23 PDLIM3 PDZ and LIM domain 3
Hs.445489 2.22 PLEKHB1 pleckstrin homology domain containing, family B (evectins), 
member 1
Hs.1722 2.21 IL1A interleukin 1, alpha
Hs.466871 2.21 PLAUR plasminogen activator, urokinase receptor
Hs.159291 2.20 DRP2 dystrophin-related protein 2
Hs.303649 2.19 CCL2 chemokine (C-C motif) ligand 2
Hs.111944 2.19 CYP3A7 cytochrome P450, family 3, subfamily A, polypeptide 7
Hs.533683 2.19 FGFR2 ﬁbroblast growth factor receptor 2
Hs.50550 2.19 KBTBD10 kelch repeat and BTB (POZ) domain containing 10
Hs.78944 2.19 RGS2 regulator of G-protein signaling 2, 24 kDa
Hs.190783 2.17 HAL histidine ammonia-lyase
Hs.463059 2.17 STAT3 signal transducer and activator of transcription 3 (acute-
phase response factor)
Hs.25647 2.16 FOS v-fos FBJ murine osteosarcoma viral oncogene homolog
Hs.127022 2.14 PTPRE protein tyrosine phosphatase, receptor type, E
Hs.447899 2.13 SIGLEC8 sialic acid-binding Ig-like lectin 8
Hs.344812 2.13 TREX1 three prime repair exonuclease 1
Hs.528670 2.12 MMP25 matrix metalloproteinase 25
Hs.514913 2.11 SERPINB2 serine (or cysteine) proteinase inhibitor, clade B 
(ovalbumin), member 2
Hs.506381 2.07 FGD6 FYVE, RhoGEF and PH domain containing 6
Hs.278658 2.06 KRTHB6 keratin, hair, basic, 6 (monilethrix)
Hs.439060 2.08 CLDN1 claudin 1
Hs.507348 2.05 HS3ST1 heparan sulfate (glucosamine) 3-O-sulfotransferase 1
Only genes with known protein products are shown. 
aGene annotations are from NCBI (http://www.ncbi.nlm.nih.gov). bFold changes are the average of four individuals. classiﬁed into 14 biologic processes containing
at least three gene hits.
Identification of genes differentiating V
from Zn. To identify genes that would discrim-
inate V from Zn, we ﬁrst analyzed V:Zn ratios
using the same statistical ﬁltration method. A
total of 163 genes were identiﬁed. The results
of the hierarchical clustering analysis using these
genes are shown in Figure 2. We next com-
pared biologic processes associated with V with
those associated with Zn. We found that four
biologic processes, regulation of transcription
(24 genes), DNA-dependent transcription
(22 genes), inﬂammatory responses (11 genes),
and regulation of cell proliferation (10 genes),
contained a disproportionately greater number
of V-induced genes. Because all genes involved
in the DNA-dependent transcription pathway
were also ﬂagged in the regulation of transcrip-
tion pathway, these two processes were com-
bined into one, designated “gene transcription.”
The number of probe sets in the three biologic
pathways associated with V and Zn treatment
was compared using the Fisher’s exact test. The
p-values for these three pathways, gene tran-
scription, inﬂammatory response, and regula-
tion of cell proliferation, are 0.004, 0.037, and
0.013, respectively.
We next matched genes in these three
pathways with the 163 genes and identified
12 candidate genes: B-cell CLL/lymphoma 6
(BCL6), IL1α (IL1A), IL8, PTGS2, DTR,
chemokine (C-X-C motif) ligand 3 (CXCL3),
promyelocytic leukemia (PML), sine oculis
homeobox homolog 1 (Drosophila) (SIX1),
tumor necrosis factor (TNF), α-induced pro-
tein 3 (TNFAIP3), Zn ﬁnger and BTB domain
containing 1 (ZBTB1), Zn ﬁnger protein 44
(KOX 7) (ZNF44), and Zn ﬁnger protein 450
(ZNF450). The hierarchical cluster analysis
showed that these 12 genes clearly discrimi-
nated the V group from the Zn group
(Figure 2) and could be separated into two
clusters (Figure 2). Cluster 1 contained
ZBTB1, PML, ZNF44, SIX1, BCL6, and
ZNF450 that were down-regulated by V and
involved in gene transcription. Cluster 2 con-
tained IL8, IL1A, PTGS2, DTR, TNFAIP3,
and CXCL3 that were up-regulated and linked
primarily to inflammatory response and cell
proliferation. We also noted metallothionein 1
genes were up-regulated by Zn but not by V.
Zn treatment increased the expression of
MT1F by 4.6-fold, MT1G by 29-fold, and
MT1K by 81-fold. These metallothionein 1
genes constituted the third group of candidate
biomarker genes.
Discussion
In the present study we first determined the
differential gene expression patterns in HBECs
exposed to 50 µM of V and Zn and found 140
and 76 genes altered by V and Zn, respectively,
compared with control. These genes could be
Li et al.
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Table 2. Genes down-regulated by VOSO4.
Gene 
accession no.a Fold changeb Gene symbola Gene namea
Hs.441975 –11.75 HSXIAPAF1 XIAP-associated factor-1
Hs.370503 –8.11 FYB FYN-binding protein (FYB-120/130)
Hs.76884 –7.48 ID3 inhibitor of DNA binding 3, dominant negative helix-loop-
helix protein
Hs.520506 –7.37 FBXO5 F-box only protein 5
Hs.22393 –6.90 DENR density-regulated protein
Hs.433060 –6.86 ACPP acid phosphatase, prostate
Hs.37045 –6.77 PTH parathyroid hormone
Hs.282410 –6.69 CALM1 calmodulin 1 (phosphorylase kinase, delta)
Hs.474251 –6.60 SCARF2 scavenger receptor class F, member 2
Hs.534101 –5.89 MYO3B myosin IIIB
Hs.442578 –5.53 LHX9 LIM homeobox 9
Hs.292356 –5.29 CYBB cytochrome b-245, beta polypeptide (chronic granulomatous 
disease)
Hs.1973 –5.21 CCNF cyclin F
Hs.24684 –5.12 ARRDC3 arrestin domain containing 3
Hs.350756 –4.44 STAU2 staufen, RNA-binding protein, homolog 2 (Drosophila)
Hs.133892 –4.41 TPM1 tropomyosin 1 (alpha)
Hs.24120 –4.23 ZNF44 zinc ﬁnger protein 44 (KOX 7)
Hs.275243 –3.89 S100A6 S100 calcium-binding protein A6 (calcyclin)
Hs.526464 –3.71 PML promyelocytic leukemia
Hs.522090 –3.55 GALT galactose-1-phosphate uridylyltransferase
Hs.432424 –3.51 TPP2 tripeptidyl peptidase II
Hs.485233 –3.47 MAPK14 mitogen-activated protein kinase 14
Hs.434924 –3.44 RIMS3 regulating synaptic membrane exocytosis 3
Hs.75294 –3.38 CRH corticotropin-releasing hormone
Hs.173984 –3.16 TBX1 T-box 1
Hs.444106 –3.11 TOR2A torsin family 2, member A
Hs.254042 –3.02 BAT1 HLA-B associated transcript 1
Hs.75862 –2.96 MADH4 MAD, mothers against decapentaplegic homolog 4 
(Drosophila)
Hs.498292 –2.89 SDCCAG8 serologically deﬁned colon cancer antigen 8
Hs.1650 –2.78 SLC26A3 solute carrier family 26, member 3
Hs.293798 –2.69 ZNF436 zinc ﬁnger protein 436
Hs.397073 –2.66 PMS2L5 postmeiotic segregation increased 2-like 5
Hs.54416 –2.63 SIX1 sine oculis homeobox homolog 1 (Drosophila)
Hs.118513 –2.59 MGC21621 G-protein-coupled receptor MrgF
Hs.129634 –2.57 CINP cyclin-dependent kinase 2-interacting protein
Hs.21388 –2.55 ZDHHC21 zinc ﬁnger, DHHC domain containing 21
Hs.131846 –2.51 TAF6L TAF6-like RNA polymerase II, p300/CBP-associated factor 
(PCAF)-associated factor, 65 kDa
Hs.116622 –2.46 ZFP30 likely ortholog of mouse zinc ﬁnger protein 30
Hs.478588 –2.41 BCL6 B-cell CLL/lymphoma 6 (zinc ﬁnger protein 51)
Hs.47712 –2.41 ZNF555 zinc ﬁnger protein 555
Hs.487774 –2.41 HNRPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1
Hs.339 –2.37 P2RY2 purinergic receptor P2Y, G-protein coupled, 2
Hs.501309 –2.35 CIRBP cold-inducible RNA-binding protein
Hs.534040 –2.33 KBTBD6 kelch repeat and BTB (POZ) domain containing 6
Hs.6093 –2.27 ARRDC4 arrestin domain containing 4
Hs.400802 –2.27 ZBTB1 zinc ﬁnger and BTB domain containing 1
Hs.474799 –2.25 PDXP pyridoxal (pyridoxine, vitamin B6) phosphatase
Hs.13982 –2.23 KCTD6 potassium channel tetramerisation domain containing 6
Hs.487561 –2.22 ICA1 islet cell autoantigen 1, 69 kDa
Hs.48297 –2.17 ZNF363 zinc ﬁnger protein 363
Hs.424926 –2.14 TM7SF1 transmembrane 7 superfamily member 1 (up-regulated in 
kidney)
Hs.101937 –2.14 SIX2 sine oculis homeobox homolog 2 (Drosophila)
Hs.409876 –2.12 ZNF450 zinc ﬁnger protein 450
Hs.63335 –2.12 TERF2 telomeric repeat binding factor 2
Hs.105633 –2.12 WINS1 WINS1 protein with Drosophila Lines (Lin) homologous 
domain
Hs.142167 –2.11 HSZFP36 ZFP-36 for a zinc ﬁnger protein
Hs.186424 –2.09 BCOR BCL6 co-repressor
Hs.518438 –2.08 SOX2 SRY (sex determining region Y)-box 2
Hs.195710 –2.08 ZNF503 zinc ﬁnger protein 503
Hs.535499 –2.02 RARA retinoic acid receptor, alpha
Hs.310640 –2.02 T2BP TRAF2-binding protein
Hs.513645 –2.02 PAK6 p21(CDKN1A)-activated kinase 6
Hs.131494 –2.00 ARNT aryl hydrocarbon receptor nuclear translocator
Only genes with known protein products are shown. 
aGenes annotations are from NCBI (http://www.ncbi.nlm.nih.gov). bFold changes are the average of four individuals. classified into 28 and 14 biologic pathways,
respectively, that each had at least three gene
hits. Seven differentially expressed genes were
validated prospectively in six additional experi-
ments using HBECs from six different individ-
uals. When the numbers of genes in the
pathways were compared between V and Zn,
three biologic processes (gene transcription,
inﬂammatory response, and regulation of cell
proliferation) contained a disproportionately
greater number of V-induced genes. We then
matched the genes in these three pathways
with the 163 genes that differentiated V from
Zn, and identiﬁed 12 candidate genes.
These 12 genes clearly discriminated the V
group from the Zn group based on the hierar-
chical clustering analysis and could be sepa-
rated into two clusters. The first cluster
consisted of 6 genes (ZBTB1, PML, ZNF44,
SIX1, BCL6, ZNF436) that were down-regu-
lated by V but mildly up-regulated by Zn. All
6 genes were involved in gene transcription,
and BCL6 was also linked to inflammatory
response and regulation of cell proliferation.
The inhibitory effects of V on the expression of
these genes have not been reported. Five of
these genes encode Zn ﬁnger proteins (ZBTB1,
ZNF44, BCL6, ZNF436) or proteins contain-
ing Zn-binding domains (PML) that play a
role in DNA binding (Bray et al. 1991; Zhong
et al. 2000). SIX1 encodes a protein character-
ized by a divergent DNA-binding homeo-
domain and an upstream SIX domain, which
may be involved in determining DNA-binding
specificity and protein–protein interactions.
Mice lacking the SIX1 gene have impaired
organogenesis of skeletal muscle and kidney
during embryo development (Laclef et al.
2003; Xu et al. 2003). Multiple adult tissues,
including the lung, also express SIX1 (Boucher
et al. 1996), but its function is unclear. The
BCL6 gene encodes a Zn ﬁnger transcription
repressor frequently associated with B-lympho-
cytes. Translocation and hypermutation of this
gene have been detected in B-cell lymphoma
(Ohno 2004). BCL6 is also expressed in the
epithelial lining of upper airways (Bajalica-
Lagercrantz et al. 1998). Based on our results,
BCL6 might be involved in gene transcription,
inﬂammatory response, and cell proliferation
in airway epithelial cells. The PML gene
encodes a Zn-binding protein in the tripartite
motif (TRIM) family and is often involved in
the translocation with the retinoic acid
receptor-α gene associated with acute pro-
myelocytic leukemia. High levels of PML
protein are expressed in human vascular
endothelial cells, epithelial cells, and macro-
phages (Flenghi et al. 1995).
Cluster 2 contained six genes that were up-
regulated by V but down-regulated or
unchanged by Zn. Four (IL8, IL1A, PTGS2,
CXCL3) were related to inflammatory
response, three (IL8, IL1A, DTR) related to
Gene profiling for vanadium and zinc
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Figure 1. Gene expression ratios measured by Q-PCR. The expression of a gene associated with V or Zn
treatment, relative to the control; n = 6 independent experiments in cells from six different individuals for
Q-PCR. Dashed line denotes an expression ratio of 1 (no change). Data are mean ± SE.
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Table 3. Genes up-regulated by ZnSO4
Gene 
accession no.a Fold changeb Gene symbola Gene namea
Hs.188518 81.01 MT1K metallothionein 1K
Hs.433391 28.87 MT1G metallothionein 1G
Hs.283678 8.40 PCDHB14 protocadherin beta 14
Hs.412196 8.09 ESRRBL1 estrogen-related receptor beta-like 1
Hs.502182 5.46 BDNF brain-derived neurotrophic factor
Hs.517581 4.78 HMOX1 heme oxygenase (decycling) 1
Hs.165736 4.67 SCAND2 SCAN domain containing 2
Hs.519469 4.65 SLC30A1 solute carrier family 30 (zinc transporter), member 1
Hs.513626 4.58 MT1F metallothionein 1F (functional)
Hs.154296 4.58 TLL2 tolloid-like 2
Hs.303090 3.94 PPP1R3C protein phosphatase 1, regulatory (inhibitor) subunit 3C
Hs.118354 3.66 PRR3 proline-rich polypeptide 3
Hs.466891 3.55 ZNF233 zinc ﬁnger protein 233
Hs.59889 3.47 HMGCS2 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 
(mitochondrial)
Hs.278973 3.33 ANGPT4 angiopoietin 4
Hs.73962 3.31 EPHA7 EphA7
Hs.445835 3.22 SERTAD4 SERTA domain containing 4
Hs.352241 3.09 TAS2R40 taste receptor, type 2, member 40
Hs.78036 3.08 SLC6A2 solute carrier family 6 (neurotransmitter transporter, 
noradrenalin), member 2
Hs.89714 3.05 CXCL5 chemokine (C-X-C motif) ligand 5
Hs.195471 3.02 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
Hs.460260 3.02 AKR1C2 aldo-keto reductase family 1, member C2
Hs.16064 2.98 MAGI1 membrane-associated guanylate kinase interacting 
protein-like 1
Hs.143036 2.81 CABP4 calcium-binding protein 4
Hs.488671 2.67 BAZ1B bromodomain adjacent to zinc ﬁnger domain, 1B
Hs.444450 2.62 EGLN1 egl nine homolog 1 (C. elegans)
Hs.465642 2.59 SEMA6B sema domain, transmembrane domain (TM), and cyto
plasmic domain, (semaphorin) 6B
Hs.32374 2.57 DTX3 deltex 3 homolog (Drosophila)
Hs.405667 2.49 CD8B1 CD8 antigen, beta polypeptide 1 (p37)
Hs.516664 2.48 EFNA1 ephrin-A1
Hs.487188 2.46 MLLT4 myeloid/lymphoid or mixed-lineage leukemia (trithorax 
homolog, Drosophila); translocated to, 4
Hs.6638 2.33 MYEF2 myelin expression factor 2
Hs.150136 2.25 MAPK7 mitogen-activated protein kinase 7
Hs.372000 2.24 NSMAF neutral sphingomyelinase (N-SMase) activation 
associated factor
Hs.194721 2.21 NCR2 natural cytotoxicity triggering receptor 2
Hs.508720 2.19 RAB20 RAB20, member RAS oncogene family
Hs.522610 2.18 LOC119180 lysozyme 2
Hs.75535 2.16 FOXN4 forkhead box N4
Hs.485572 2.11 SOCS2 suppressor of cytokine signaling 2
Hs.521171 2.09 HIG2 hypoxia-inducible protein 2
Hs.80288 2.05 HSPA1L heat-shock 70 kDa protein 1-like
Hs.123450 2.03 JPH3 junctophilin 3
Hs.441047 2.01 ADM adrenomedullin
Only genes with known protein products are shown. 
aGene annotations are from NCBI (http://www.ncbi.nlm.nih.gov). bFold changes are the average of four individuals. regulation of cell proliferation, and two
(DTR, TNFAIP3) related to gene transcrip-
tion. Vanadium is known to induce IL8 in
cultured bronchial epithelial cells (Carter
et al. 1997; Mukherjee et al. 2004) and in the
nasal ﬂuid of workers exposed to V-rich pol-
lutant particles (Woodin et al. 1998).
Exposure to pollutant particles with high con-
centrations of V and Ni increased expression
of PTSG2 (COX2) in nasal epithelial cells of
dogs (Calderon-Garciduenas et al. 2003).
Vanadium also increased the expression of
DTR [heparin-binding epidermal growth fac-
tor-like growth factor (HB-EGF)] in HBECs
and fibroblasts (Ingram et al. 2003; Zhang
et al. 2001). The stimulatory effects of V on
IL1A and TNFAIP3 gene expression, however,
have not been reported. IL1A is one of the
nine genes in the IL1 gene family and is
involved in various immune responses, inﬂam-
matory processes, and hematopoiesis (Arend
2002). TNFAIP3 (A20) is a Zn ﬁnger protein
that is rapidly induced by TNF. It inhibits
NF-κB activation as well as TNF-mediated
apoptosis (Gon et al. 2004; He and Ting
2002; Wertz et al. 2004). The CXCL3
(GRO-γ) gene is a member of a gene superfam-
ily encoding a set of related cytokines with
inﬂammatory and growth regulatory properties
(Haskill et al. 1990). Constitutive expression of
CXCL3 has been identified in infiltrating
leukocytes, bronchial epithelial cells, alveolar
type II cells, and alveolar macrophages (Becker
et al. 1994; Johnson et al. 1996). Several
inflammatory stimuli, including IL1, TNF,
lipopolysaccharide, and silica, induce the
expression of CXCL3 (Becker et al. 1994;
Haskill et al. 1990; Johnson et al. 1996;
Rangnekar et al. 1991). Note that chemokine
(C-X-C motif) ligand 1 (CXCL1) was also
up-regulated by V (Table 1). Thus, it appears
that the signaling pathways involving IL1,
TNF, and chemokines activation may be novel
targets for V and may play an important role in
V-induced acute respiratory syndrome in boil-
ermakers and power plant workers (Levy et al.
1984; Woodin et al. 2000). Up-regulation of
IL1A and other growth-related genes (e.g.,
DTR, FOS, CXCL1, and EDN1) also indicates
that the IL1A pathway may be also involved in
clinical conditions associated with cell growth,
such as ﬁbrosis (Bonner et al. 1998, 2000).
Although not selected because they were
not matched to any known pathways, several
metallothionein 1 genes (MT1F, MT1G,
MT1K) were signiﬁcantly up-regulated by Zn.
Metallothioneins (MT) are low-molecular-
weight metal- and sulfur-rich proteins widely
distributed in the organs, including the lung
(Courtade et al. 1998). These intracellular pro-
teins are thought to be involved in heavy metal
detoxiﬁcation and the homeostasis of essential
trace metals, such as Zn and copper (Kagi
1993; Karin 1985). Exposure to zinc oxide
Li et al.
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Table 4. Genes down-regulated by ZnSO4.
Gene  Fold
accession no.a changeb Gene symbola Gene namea
Hs.376873 –6.25 ZNF390 zinc ﬁnger protein 390
Hs.106513 –6.09 TLL1 tolloid-like 1
Hs.200929 –5.87 IL23R interleukin-23 receptor
Hs.268581 –5.47 LPIN2 lipin 2
Hs.112218 –5.36 CAPN10 calpain 10
Hs.532082 –5.23 IL6ST interleukin 6 signal transducer (gp130, oncostatin M receptor)
Hs.483136 –4.53 COMMD10 COMM domain containing 10
Hs.141308 –4.39 MOG myelin oligodendrocyte glycoprotein
Hs.7138 –4.10 CHRM3 cholinergic receptor, muscarinic 3
Hs.120633 –4.08 SESN3 sestrin 3
Hs.512587 –3.58 MST1 macrophage stimulating 1 (hepatocyte growth factor-like)
Hs.370510 –3.23 IGSF4 immunoglobulin superfamily, member 4
Hs.533040 –3.21 PDLIM7 PDZ and LIM domain 7 (enigma)
Hs.552578 –3.03 TCF1 transcription factor 1, hepatic; LF-B1, hepatic nuclear 
factor (HNF1), albumin proximal factor
Hs.472558 –2.92 SDBCAG84 serologically deﬁned breast cancer antigen 84
Hs.506394 –2.77 ubiquitin speciﬁc protease 44
Hs.438994 –2.69 ZNF544 zinc ﬁnger protein 544
Hs.32721 –2.61 SAG S-antigen; retina and pineal gland (arrestin)
Hs.74082 –2.48 KLRC3 killer cell lectin-like receptor subfamily C, member 3
Hs.382683 –2.47 PRG-3 plasticity-related gene 3
Hs.522291 –2.42 PRKWNK2 protein kinase, lysine deﬁcient 2
Hs.493275 –2.34 TRIM31 tripartite motif-containing 31
Hs.129895 –2.29 TBX3 T-box 3 (ulnar mammary syndrome)
Hs.546263 –2.29 KIR3DL2 killer cell immunoglobulin-like receptor, three domains, 
long cytoplasmic tail, 2
Hs.546354 –2.21 RRP4 homolog of yeast RRP4 (ribosomal RNA processing 4), 
3´-5´-exoribonuclease
Hs.19385 –2.17 ABHD5 abhydrolase domain containing 5
Hs.344400 –2.19 MPHOSPH6 M-phase phosphoprotein 6
Hs.411311 –2.17 IL24 interleukin 24
Hs.492236 –2.17 H326 H326
Hs.255432 –2.06 CIB3 calcium and integrin binding family member 3
Hs.476052 –2.02 SNRK SNF-1 related kinase
Hs.432898 –2.01 MAP3K13 mitogen-activated protein kinase kinase kinase 13
Only genes with known protein products are shown. 
aGene annotations are from NCBI (http://www.ncbi.nlm.nih.gov). bFold changes are the average of four individuals.
Figure 2. The hierarchical clustering analysis for the 163 genes that discriminated V from Zn (A) and the
12 genes from this list identiﬁed by additional ﬁltration algorithms described in the text (B). Each row repre-
sents one single gene, and each column represents one experiment. Red areas are up-regulation, and green
areas are down-regulation, relative to control. The 12 genes clearly discriminate between the V group and
the Zn group. The analysis also divided the genes into two clusters. Gene names are from NCBI (http://www.
ncbi.nlm.nih.gov/).
Clusters in
gene tree
Cluster 1
Cluster 2
A
Bfume increased mRNA of MTs in rat lungs
(Cosma et al. 1992). Systemic administration
of Zn enhanced MT levels in the liver (Conrad
et al. 1997). Mice lacking MTs were more sen-
sitive to Zn toxicity compared with wild-type
mice (Park et al. 2001). In our study, in
addition to increases in MT1F (4.6-fold),
MT1G (29-fold), and MT1K (81-fold), other
MTs, although not identiﬁed by our statistical
filtration, also had elevated ratios: 1.36 for
metallothionein 1X (MT1X), 1.17 for metal-
lothionein 1H (MT1H) and 1.21 for metal-
lothionein 2A (MT2A). These results conﬁrm
that up-regulation of the MTs may represent
early cellular defense against Zn (Irato et al.
2001; Park et al. 2001) and may be used to
distinguish Zn and other heavy metals from V.
In our study, we used the one-class t-test
with a p-value of < 0.01 and a ratio cutoff of
≥ 2.0 or ≤ 0.5 to identify differentially
expressed genes. This statistical algorithm
selected 140 genes (1.0%) from V-treated cells,
76 genes (0.5%) from Zn-treated cells, and
163 genes (1.1%) that differentiated V from
Zn out of 14,500 genes in the Affymetrix
Hu133A 2.0 gene chip. We are not aware of
other large-scale genomic studies on V and Zn.
One study reported 65 differentially expressed
genes out of 1,200 genes (5.4%) associated
with 4-hr 50 µM arsenic treatment in
BEAS-2B cells, using a ratio cutoff of 2.0 and
signal difference of 13 (Andrew et al. 2003). It
is difﬁcult to compare across the different stud-
ies, but the smaller percentage of recovery of
signiﬁcant genes in our study may indicate in
part a more stringent ﬁltration method. Also,
the cells in our study were exposed to 50 µM
VOSO4 and ZnSO4, or 14 and 18 µg of ele-
mental V and Zn, respectively. These doses
would be equivalent to working 3 hr in the
environments of boilermakers and welders
with the ambient V and Zn concentrations of
8 and 10 µg/m3, respectively (Marquart et al.
1989; Woodin et al. 2000), assuming ventila-
tion of 10 L/min.
Conclusion
It has been estimated that there are approxi-
mately 25,000 boilermakers and 300,000
welders nationwide. These workers can be
exposed to high concentrations of V and Zn,
respectively, at their workplaces. Our study
compared gene expression proﬁles induced by
V and Zn in HBECs and identiﬁed a group of
12 genes and several metallothionein 1 genes
that may be used as a biomarker for V and Zn
exposure, respectively. Determining the applic-
ability of these candidate genes as biomarkers
will require exposure studies enrolling a large
number of subjects. The gene expression pro-
files provided by our study also identified
potentially novel genes and pathways involved
in the pathogenesis of health effects caused by
environmental V and Zn exposure.
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